LONDON BROKER RATINGS: Stifel raises Rentokil to 'buy' from 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 306.60p on 14-10-2026 at 12:56:48 |
|---|---|
| Change | 0.60p 0.2% |
| Buy | 306.50p |
| Sell | 306.30p |
| Last Trade: | Buy 358.00 at 306.754p |
| Day's Volume: | 2,694,391 |
| Last Close: | 306.00p |
| Open: | 307.30p |
| ISIN: | GB00B082RF11 |
| Day's Range | 306.40p - 309.50p |
| 52wk Range: | 293.50p - 506.80p |
| Market Capitalisation: | £7.71b |
| VWAP: | 307.40448p |
| Shares in Issue: | 2.52b |
Rentokil Initial (RTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 358 | 306.754p | Ordinary |
13:51:01 - 14-Oct-26 |
| Buy* | 227 | 306.60p | Automatic Execution |
13:47:13 - 14-Oct-26 |
| Buy* | 24 | 306.50p | Automatic Execution |
13:46:30 - 14-Oct-26 |
| Sell* | 4 | 306.50p | Automatic Execution |
13:45:29 - 14-Oct-26 |
| Sell* | 294 | 306.50p | Automatic Execution |
13:44:27 - 14-Oct-26 |
| Buy* | 45 | 306.70p | Automatic Execution |
13:42:44 - 14-Oct-26 |
| Buy* | 933 | 306.70p | Automatic Execution |
13:42:44 - 14-Oct-26 |
| Sell* | 1 | 306.60p | Automatic Execution |
13:40:01 - 14-Oct-26 |
| Sell* | 86 | 306.60p | Automatic Execution |
13:40:01 - 14-Oct-26 |
| Sell* | 49 | 306.60p | Automatic Execution |
13:40:01 - 14-Oct-26 |
Rentokil Initial (RTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 11:15 am | RNS | Holding(s) in Company |
| 30th Sep 2026 10:25 am | RNS | Holding(s) in Company |
| 22nd Sep 2026 7:00 am | RNS | Sale of SOLitude Lake Management, LLC |
| 27th Aug 2026 3:00 pm | RNS | Interim Dividend – Pence Sterling Amount Payable |
| 13th Aug 2026 9:30 am | RNS | Organisational Changes & Leadership Appointments |
| 4th Aug 2026 10:30 am | RNS | Holding(s) in Company |
| 3rd Aug 2026 1:00 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 16th Jul 2026 10:00 am | RNS | Director Declaration |
| 21st May 2026 7:00 am | RNS | Appointment of CEO, North America |